Clinical value and influencing factors of acoustic attenuation imaging in the diagnosis of metabolic fatty liver
返回论文页
|更新时间:2023-10-11
|
Clinical value and influencing factors of acoustic attenuation imaging in the diagnosis of metabolic fatty liver
Journal of Clinical Ultrasound in MedicineVol. 25, Issue 1, Pages: 8-12(2023)
作者机构:
广西中医药大学第一附属医院
作者简介:
基金信息:
DOI:
CLC:
Published:2023,
Published Online:31 January 2023,
扫 描 看 全 文
Clinical value and influencing factors of acoustic attenuation imaging in the diagnosis of metabolic fatty liver. [J]. Journal of Clinical Ultrasound in Medicine 25(1):8-12(2023)
DOI:
Clinical value and influencing factors of acoustic attenuation imaging in the diagnosis of metabolic fatty liver. [J]. Journal of Clinical Ultrasound in Medicine 25(1):8-12(2023)DOI:
Clinical value and influencing factors of acoustic attenuation imaging in the diagnosis of metabolic fatty liver
Abstract: Objective To explore the clinical value and influencing factors of noninvasive ultrasound attenuation imaging (ATI) in the diagnosis of metabolic fatty liver disease (MAFLD).Methods 122 subjects were recruited from the physical examination department
hepatology department and endocrinology department of our hospital for a prospective study. They were divided into 31 healthy volunteers (normal control group) and 91 patients with MAFLD (MAFLD group). All subjects were examined by abdominal two-dimensional ultrasound
ATI
controlled attenuation imaging (CAP) and serology. The differences of the above indicators between the two groups were compared. Based on the results of CAP examination
the ROC curve of subjects was drawn to analyze the efficacy of ATI in the diagnosis of fatty liver at different levels
and the correlation between ATI and CAP
ATI and two-dimensional ultrasound grading in the diagnosis of fatty liver
as well as the influence of various clinical data on the attenuation coefficient (AC) value.Results There were significant differences in body mass index
triglyceride
alanine aminotransferase and glutamic oxaloacetic transaminase between MAFLD group and normal control group (all P<0.05). The AC value of MAFLD group was (0.79 ± 0.11) dB · cm-1 · MHz-1
which was higher than that of healthy control group (0.58 ± 0.45) dB · cm-1 · MHz-1. The AC value increased with the increase of fatty liver degree
and the difference was statistically significant (all P<0.05). ROC curve analysis showed that the cutoff value of AC value in diagnosis of ≥ S1
≥ S2
≥ S3 fatty liver was 0.64
0.70
0.79 dB · cm-1 · MHz-1
the sensitivity was 89.7%
80.6%
100%
and the specificity was 90.3%
69.0%
87.1%
respectively. Coherence analysis showed that ATI was positively correlated with CAP
ATI with two-dimensional ultrasound grading in the diagnosis of MAFLD (r=0.940
0.851
all P<0.0001); Multivariate linear regression analysis showed that the change of AC value was not affected by clinical data
but only related to the degree of fatty liver. Conclusion ATI technology has good diagnostic efficacy in diagnosing MAFLD and its degree grading
and is significantly related to CAP and two-dimensional ultrasound grading
and the change of AC value is not affected by clinical parameters
The application value of contrast-enhanced ultrasound in the evaluation of local thermal ablation of liver cancer and the analysis of the influencing factors of local tumor progression
Comparison of the efficacy of PiCCO monitoring and ultrasound in guiding early fluid resuscitation in patients with sepsis
Research progress of ultrasonic elastography in children with kidney disease
Ultrasonic diagnosis of bilateral submandibular gland Kimura disease: a case report